O-009 NETTER-1 phase III: efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate
Titel:
O-009 NETTER-1 phase III: efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate
Auteur:
Strosberg, J. Wolin, E. Chasen, B. Kulke, M. Bushnell, D. Chaplin, M. Baum, R. Kunz, P. Hobday, T. Oberg, K. Lopera Sierra, M. Kwekkeboom, D. Ruszniewski, P. Krenning, E. Hendifar, A.